Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Packard

Showing results (221-230 of 235) with videos related to

Pageof 24
Sort By:
Diabetes Research and Clinical Practice|February 13, 2001
Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic controlC E Tan, L S Chew, L F Chio, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 1, 1996
Effects of colestipol alone and in combination with simvastatin on apolipoprotein B metabolismA Gaw, C J Packard, G M Lindsay, et al.
The Journal of Clinical Investigation|December 1, 1984
Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjectsJ Shepherd, C J Packard, J M Stewart, et al.
Journal of Medical Genetics|July 25, 1998
Identification of a common low density lipoprotein receptor mutation (C163Y) in the west of ScotlandW K Lee, L Haddad, M J Macleod, et al.
Journal of Internal Medicine|December 18, 2019
Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjectsE Björnson, C J Packard, M Adiels, et al.
The New England Journal of Medicine|October 19, 2000
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study GroupC J Packard, D S O'Reilly, M J Caslake, et al.
Circulation|February 7, 2001
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention StudyD J Freeman, J Norrie, N Sattar, et al.
Clinical Chemistry|August 1, 1997
Point: status of lipid and lipoprotein standardizationJ R McNamara, E T Leary, F Ceriotti, et al.
Experimental Gerontology|May 28, 2008
Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER studyS Trompet, A J M de Craen, P Slagboom, et al.
Brain : a Journal of Neurology|February 29, 2008
Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER studyS Trompet, A J M de Craen, P Slagboom, et al.
Pageof 24

Showing results (221-230 of 235) with videos related to

Sort By:
Pageof 24
Diabetes Research and Clinical Practice|February 13, 2001
Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic controlC E Tan, L S Chew, L F Chio, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 1, 1996
Effects of colestipol alone and in combination with simvastatin on apolipoprotein B metabolismA Gaw, C J Packard, G M Lindsay, et al.
The Journal of Clinical Investigation|December 1, 1984
Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjectsJ Shepherd, C J Packard, J M Stewart, et al.
Journal of Medical Genetics|July 25, 1998
Identification of a common low density lipoprotein receptor mutation (C163Y) in the west of ScotlandW K Lee, L Haddad, M J Macleod, et al.
Journal of Internal Medicine|December 18, 2019
Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjectsE Björnson, C J Packard, M Adiels, et al.
The New England Journal of Medicine|October 19, 2000
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study GroupC J Packard, D S O'Reilly, M J Caslake, et al.
Circulation|February 7, 2001
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention StudyD J Freeman, J Norrie, N Sattar, et al.
Clinical Chemistry|August 1, 1997
Point: status of lipid and lipoprotein standardizationJ R McNamara, E T Leary, F Ceriotti, et al.
Experimental Gerontology|May 28, 2008
Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER studyS Trompet, A J M de Craen, P Slagboom, et al.
Brain : a Journal of Neurology|February 29, 2008
Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER studyS Trompet, A J M de Craen, P Slagboom, et al.
Pageof 24